FR350M - Nouvel antibiotique lankavamycine utilisable en thérapeutique. - Google Patents

Nouvel antibiotique lankavamycine utilisable en thérapeutique.

Info

Publication number
FR350M
FR350M FR836983A FR836983A FR350M FR 350 M FR350 M FR 350M FR 836983 A FR836983 A FR 836983A FR 836983 A FR836983 A FR 836983A FR 350 M FR350 M FR 350M
Authority
FR
France
Prior art keywords
lankavamycin
usable
therapy
new antibiotic
antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR836983A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH7340059A external-priority patent/CH374147A/de
Priority claimed from FR827673A external-priority patent/FR1295910A/fr
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Priority to FR836983A priority Critical patent/FR350M/fr
Application granted granted Critical
Publication of FR350M publication Critical patent/FR350M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR836983A 1959-05-20 1960-08-29 Nouvel antibiotique lankavamycine utilisable en thérapeutique. Active FR350M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR836983A FR350M (fr) 1959-05-20 1960-08-29 Nouvel antibiotique lankavamycine utilisable en thérapeutique.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH7340059A CH374147A (de) 1959-05-20 1959-05-20 Verfahren zur Herstellung eines neuen Antibiotikums
CH127660 1960-02-05
FR827673A FR1295910A (fr) 1960-05-19 1960-05-19 Procédé de préparation de deux nouveaux antibiotiques dénommés <<lankavamycine>> et <<lankavacidine>>, à partir d'une souche de streptomyces
FR836983A FR350M (fr) 1959-05-20 1960-08-29 Nouvel antibiotique lankavamycine utilisable en thérapeutique.

Publications (1)

Publication Number Publication Date
FR350M true FR350M (fr) 1961-03-27

Family

ID=25687181

Family Applications (1)

Application Number Title Priority Date Filing Date
FR836983A Active FR350M (fr) 1959-05-20 1960-08-29 Nouvel antibiotique lankavamycine utilisable en thérapeutique.

Country Status (2)

Country Link
FR (1) FR350M (fr)
GB (1) GB949473A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120316106A1 (en) * 2009-12-29 2012-12-13 Yeda Research And Development Co. Ltd. Synergistic antibiotic combinations and derivatives

Also Published As

Publication number Publication date
GB949473A (en) 1964-02-12

Similar Documents

Publication Publication Date Title
FR369M (fr) Halogénotétracyclines.
FR308M (fr) Nouvelle pyridyl-éthyl-guanidine utilisable en thérapeutique.
BE596003A (fr) Amino-hydroxy-nitriles.
FR302M (fr) Nouvelle m-butoxy-phénoxy-éthylamine utilisable en thérapeutique.
FR350M (fr) Nouvel antibiotique lankavamycine utilisable en thérapeutique.
FR1898M (fr) Nouvelle substance utilisable en thérapeutique.
FR351M (fr) Nouvel antibiotique lankavacidine utilisable en thérapeutique.
FR352M (fr) Nouvel antibiotique ferrimycine utilisable en thérapeutique.
OA01426A (fr) Synchro-machines perfectionnées.
DK103424C (da) Høvender.
DK120015B (da) Fluidistor.
BE595070A (fr) Plansichter.
FR353M (fr) Nouvelle quinoléine utilisable en thérapeutique.
FR309M (fr) Nouvelle pipérazino-éthyl-guanidine utilisable en thérapeutique.
FR1233212A (fr) Cystoscope utilisable en pédiatrie
DK95557C (da) Glashus.
FR222M (fr) Nouvelle 2,5-bis-éthylene-imino-3,6-bis-acylamino-p-benzoquinone utilisable en thérapeutique.
FR348M (fr) Nouveau glucofuranoside 3,5,6-substitué utilisable en thérapeutique.
FR1029M (fr) Nouveau 17α-isobutyl-androstane-3β,17β-diol utilisable en thérapeutique.
BE596272A (fr) Nouvelle substance utilisable en thérapeutique.
FR303M (fr) Nouvelle guanidine utilisable en thérapeutique.
FR3174M (fr) Nouvel δ-3β17β-dihydroxy-7α17α-diméthyl-19-nor-androstene utilisable en thérapie.
FR163M (fr) Nouvelle phénoxy-éthylamine utilisable en thérapeutique.
BE583857A (fr) Agent opacifiant utilisable en radiologie.
FR269M (fr) Nouvelles substances antibiotiques.